WikiJournalClub:Trial Acronyms

From Wiki Journal Club
Jump to: navigation, search
4S
Scandinavian Simvastatin Survival Study
A-HeFT
African-American Heart Failure Trial
AAPAC
Appendicitis Acuta
AATAC
Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device
ACCOMPLISH
Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension
ACCORD
Action to Control Cardiovascular Risk in Diabetes
ACCORD BP
ACCORD Study Group
ACCORD Lipid
Action to Control Cardiovascular Risk in Diabetes-Lipid
ACOSOG Z0011
The American College of Surgeons Oncology Group (ACOSOG) Z0011
ACT
Acetylcysteine for Contrast-Induced Nephropathy Trial
ACTIVE A
Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events
ACTIVE W
Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events
ACURASYS
ARDS et Curarisation Systematique
ADJUST-PE
Age aDJUSTed D-Dimer to rule out PE
ADRENAL
Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock
ADVANCE
Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation
AF-CHF
Atrial Fibrillation and Congestive Heart Failure
AFFIRM
Atrial Fibrillation Follow-up Investigation of Rhythm Management
AIDA
Amsterdam Investigator-Initiated Absorb Strategy All-Comers Trial
AIRTRIP
AnakInRa for Treatment of Recurrent Idiopathic Pericarditis
AKIKI
Artificial Kidney Initiation in Kidney Injury
ALBIOS
Albumin Italian Outcome Sepsis
ALLHAT
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
ALMS
Aspreva Lupus Management Study
AMPLIFY
Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy
AMPLIFY-EXT
Apixaban after the Initial Management of Pulmonary Embolism and Deep Vein Thrombosis with First-Line Therapy-Extended Treatment
ANNEXA
Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of FXA Inhibitors
ANNEXA-4
Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of Factor Xa Inhibitors
APEX
Acutely Medically Ill VTE Prevention with Extended Duration Betrixaban
ARDSNet
Acute Respiratory Distress Syndrome Network
ARISE
Australasian Resuscitation in Sepsis Evaluation
ARISTOTLE
Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation
ARREST
Adjunctive rifampicin for Staphylococcus Aureus Bacteraemia
ART
Arterial Revascularization Trial
ASCEND
A Study of Cardiovascular Events in Diabetes
ASCEND
Assessment of Pirfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis
ASPIRE
Aspirin to Prevent Recurrent Venous Thromboembolism
ASPREE
Aspirin in Reducing Events in the Elderly
ASTRAL
Angioplasty and Stenting for Renal Artery Lesions
ATHOS-3
Angiotensin II for the Treatment of High-Output Shock
ATLAS
Adjuvant Tamoxifen: Longer Against Shorter
ATLAS ACS 2-TIMI 51
Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 51
ATN
Acute Renal Failure Trial Network Study
ATTR-ACT
The Transthyretin Amyloidosis Cardiomyopathy Clinical Trial
ATTRACT
Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis
AURORA
A Study to Evaluate the Use of Rosuvastatin in Subjects on Regular Hemodialysis: An Assessment of Survival and Cardiovascular Events
AVERROES
Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment
AVERT
Apixaban for the Prevention of Venous Thromboembolism in High-Risk Ambulatory Cancer Patients
AVOID
Comparing Oxygen with normal air in patients with ST-Segment Elevation Myocardial Infarction who are not hypoxic.
BARI 2D
Bypass Angioplasty Revascularization Investigation 2 Diabetes
BASALT
Best Adjustment Strategy for Asthma in the Long Term
BEST
The Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation
BICAR-ICU
Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill: A Multiple Center Randomized Clinical Trial
BLOCK-HF
Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block
BRIDGE
Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for Elective Invasive Procedure or Surgery
BRIM-3
BRAF Inhibitor in Melanoma 3
BeSt
Behandel-Strategeieën ("treatment strategies" in Dutch)
Blood-Pressure Reduction in Black Barbershops
Blood-Pressure Reduction in Black Barbershops
CABANA
Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation
CAMERA
Computer Assisted Management in Early Rheumatoid Arthritis
CANTOS
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
CANVAS
Canagliflozin Cardiovascular Assessment Study
CAP-START
Community-Acquired Pneumonia—Study on the Initial Treatment with Antibiotics of Lower Respiratory Tract Infections
CAPRICORN
Carvedilol Post-Infarct Survival Control in LV Dysfunction
CAPRIE
Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events
CARRESS-HF
Cardiorenal Rescue Study in Acute Decompensated Heart Failure
CASSINI
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer
CAST I
Cardiac Arrhythmia Suppression Trial
CASTLE-AF
Catheter Ablation versus Standard Conventional Therapy in Patients with Left Ventricular Dysfunction and Atrial Fibrillation
CATIE
Clinical Antipsychotic Trials of Intervention Effectiveness
CATIE-AD
Clinical Antipsychotic Trials of Intervention Effectiveness–Alzheimer's Disease
CATT
Comparison of Age-Related Macular Degeneration Treatment Trails
CHAMPION PHOENIX
Cangrelor versus standard therapy to achieve optimal management of platelet inhibition
CHANCE
Clopidogrel in High-risk patients with Acute Nondisabling Cerebrovascular Events
CHARISMA
Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance
CHARM-Preserved
Candesartan in Heart failure Assessment of Reduction in Mortality and Morbidity-Preserved
CHOICE
CHOICE is not an abbreviation per a communication with the research team
CHOIR
Correction of Hemoglobin and Outcomes in Renal Insufficiency
CIRT
Cardiovascular Inflammation Reduction Trial
CLOSURE I
Evaluation of the STARFlex Septal Closure System in Patients with a Stroke and/or Transient Ischemic Attack due to Presumed Paradoxical Embolism through a Patent Foramen Ovale
CLOT
Comparison of Low Molecular Weight Heparin Versus Oral Anticoagulant Therapy for Long Term Anticoagulation in Cancer Patients With Venous Thromboembolism
COAPT
Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation
COGENT
Clopidogrel and the Optimization of Gastrointestinal Events Trial
COMET
Carvedilol Or Metoprolol European Trial
COMMIT/CCS-2
ClOpidogrel and Metoprolol in Myocardial Infarction Trial / Second Chinese Cardiac Study
COMPASS
Cardiovascular Outcomes for People Using Anticoagulation Stratgies
CONSENSUS
Cooperative North Scandinavian Enalapril Survival Study
COPERNICUS
Carvedilol Prospective Randomized Cumulative Survival
CORONA
Controlled Rosuvastatin Multinational Trial in Heart Failure
CORTICUS
Corticosteroid Therapy of Septic Shock
COURAGE
Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
CRASH-2
Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2
CREDENCE
Canagliflozin and Renal Events in Diabetes and Nephropathy Clinical Evaluation
CREST
Carotid Revascularization Endarterectomy vs. Stenting Trial
CRISTAL
Colloids Versus Crystalloids for the Resuscitation of the Critically Ill
CSG Captopril Trial
Collaborative Study Group Captopril Trial
CULPRIT-SHOCK
Culprit Lesion Only PCI versus Multivessel PCI in Cardiogenic Shock
CURE
Clopidogrel in Unstable Angina to Prevent Recurrent Events
CYTO-PV
Cytoreductive Therapy in Polycythemia Vera
CvLPRIT
Complete Versus Lesion-Only Primary PCI Trial
DANAMI-3 PRIMULTI
Third Danish Study of Optimal Acute Treatment of Patients with STEMI: Primary PCI in Multivessel Disease
DANISH
Danish Study to Assess the Efficacy of ICDs in Patients with Non-ischemic Systolic Heart Failure on Mortality
DAPT
Dual Antiplatelet Therapy
DASH
Dietary Approaches to Stop Hypertension
DAVID
Dual-chamber pacing or ventricular backup pacing in ICD patients
DCCT
Diabetes Control and Complications Trial
DEFINITE
Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation
DETO2X-AMI
Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction
DIG
Digitalis Investigation Group
DIVA
Rationale and design of the drug-eluting stents vs bare-metal stents in saphenous vein graft angioplasty
DODS
D-dimer Optimal Duration Study
DONATE HCV
Donors of Hepatitis C NAT Positive Thoracic Allografts for Transplantation Evaluation in Non-HCV Recipients
DOSE
Diuretic Optimization Strategies Evaluation
DPP
Diabetes Prevention Program
ECASS III
European Cooperative Acute Stroke Study III
ECST
European Carotid Surgery Trial
EDIC
Epidemiology of Diabetes Interventions and Complications
EDS
European Dexamethasone Study
EINSTEIN CHOICE
Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic Venous Thromboembolism
ELITE-Symphony
Efficacy Limiting Toxicity Elimination-Symphony
EMBRACE
30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation after a Cerebral Ischemic Event
EMILIA
Emtansine vs. Capecitabine+Lapatinib in Patients with HER2-Positive Locally Advanced or Metastatic Breast Cancer
EMPHASIS-HF
Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure
ENGAGE AF-TIMI 48
Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation - Thrombolysis in Myocardial Infarction 48
EPCAT II
Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty II
EPHESUS
Eplerenone Post–Acute Myocardial Infarction Heart Failure Efficacy and Survival Study
ERSPC
European Randomized Study of Screening for Prostate Cancer
ESCAPE
Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness
ESPRIT
European/Australasian Stroke Prevention in Reversible Ischaemia Trial
ESSENCE
Efficacy and Safety of Subcutaneous Enoxaparin in Non–Q-Wave Coronary Events Study Group
EUCLID
Examining use of ticagrelor in peripheral artery disease
EUROPA
European Trial on Reduction of Cardiac Events with Perindopril in Patients with Stable Coronary Artery Disease
EVEREST
Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan
EVOLVE
Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
EXCEL
XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL)
EXTRA
A Study of Omalizumab/Xolair in Subjects With Moderate to Severe Persistent Asthma
FACTT
Fluids and Catheters Treatment Trial
FAIR-HF
IV Iron for Symptoms in Patients with HFrEF and Iron Deficiency
FAME
Fractional Flow Reserve versus Angiography for Multivessel Evaluation
FAME 2
FFR vs. Angiographyfor Multivessel Evaluation 2
FEAST
Fluid Expansion as Supportive Therapy
FLAME
Fluoxetine for Motor Recovery after Acute Ischaemic Stroke
FLAME COPD
Effect of Indacaterol Glycopyronium Vs. Fluticasone Salmeterol on COPD Exacerbations
FOCUS
Transfusion Trigger Trial for Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair
FOURIER
Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk
FREEDOM
Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease
GISSI-3
Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico
GUSTO
Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries
HACA
Hypothermia After Cardiac Arrest
HEARTMATE II
Advanced heart failure treated with continuous-flow left ventricular assist device
HEAT
Permissive Hyperthermia through Avoidance of Acetaminophen in Known or Suspected Infection in the Intensive Care Unit
HEMO
Hemodialysis
HERA
Herceptin Adjuvant Trial
HOPE
Heart Outcomes Prevention Evaluation
HPS2-THRIVE
Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events
HPTN 052
HIV Prevention Trials Network 052 Study
HYVET
Hypertension in the Very Elderly Trial
IABP-SHOCK II
Intraaortic Balloon Pump in Cardiogenic Shock II
IALT
International Adjuvant Lung Cancer Trial
ICAP
Evaluation of additive benefit of colchicine to conventional therapy in acute pericarditis
IDEAL
Initiating Dialysis Early and Late
IDEAL-ICU
Initiation of Dialysis Early Versus Delayed in the Intensive Care Unit
IDNT
Irbesartan Diabetic Nephropathy Trial
IMPROVE-IT
IMProved Reduction of Outcomes: Vytorin Efficacy International Trial
IRIS
International Randomized Study of Interferon and STI571
IRONOUT-HF
Iron Repletion Effects on Oxygen Uptake in Heart Failure
ISAR-TRIPLE
Triple therapy in Patients who Require Oral Anticoagulation After Drug-Eluting Stent Implantation
ISIS-2
Second International Study of Infarct Survival
IST
International Stroke Trial
JUPITER
Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin
LEADER
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
LESS
Lumbar Epidural Steroid Injections for Spinal Stenosis
LoDoCo
Low-Dose Colchicine
Look AHEAD
Look Action for HEAlth in Diabetes
MADIT-CRT
Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy
MADIT-II
Multicenter Automatic Defibrillator Implantation Trial II
MAGELLAN
Multicenter, Randomized, Parallel Group Efficacy and Safety Study for the Prevention of Venous Thromboembolism in Hospitalized Acutely Ill Medical Patients Comparing Rivaroxaban with Enoxaparin
MARINER
Medically Ill Patient Assessment of Rivaroxaban versus Placebo in Reducing Post-Discharge Venous Thrombo-Embolism Risk
MASS
Multicentre Aneurysm Screening Study
MATCH
Management of Atherothrombosis with Clopidogrel in High-risk patients
MERIT-HF
Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure
METEOR
Meniscal Tear in Osteoarthritis Research
MIDA
Mitral Regurgitation International Database
MIND-USA
Modifying the Impact of ICU-Associated Neurological Dysfunction–USA
MIRACL
Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering
MOMENTUM 3
Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3
MOPETT
Moderate Pulmonary Embolism Treated with Thrombolysis
MPACT
Metastatic Pancreatic Adenocarcinoma Clinical Trial
MSH
Multicenter Study of Hydroxyurea in Sickle-Cell Anemia
MUSTT
Multicenter Unsustained Tachycardia Trial
NA-ACCORD
North American AIDS Cohort Collaboration on Research and Design
NASCET
North American Symptomatic Carotid Endarterectomy Trial
NCDS
The National Cooperative Dialysis Study
NEAT-HFpEF
Nitrate’s Effect on Activity Tolerance in Heart Failure with Preserved Ejection Fraction
NETT
National Emphysema Treatment Trial
NICE-SUGAR
Normoglycemia in Intensive Care Evaluation and Surviving Using Glucose Algorithm Regulation
NINDS
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study
NLST
National Lung Screening Trial
NORSTENT
Drug-Eluting or Bare-Metal Stents for Percutaneous Coronary Intervention in Stable or Unstable Coronary Artery Disease
NOTT
Nocturnal Oxygen Therapy Trial
NSABP B-32
National Surgical Adjuvant Breast and Bowel Project Trial B-32
NSABP P-1
National Surgical Adjuvant Breast and Bowel Project, Prevention-1
OASIS-5
Fifth Organization to Assess Strategies in Acute Ischemic Syndromes
ODYSSEY LONG TERM
Long-term Safety and Tolerability of Alirocumab in High Cardiovascular Risk Patients with Hypercholesterolemia Not

Adequately Controlled with Their Lipid Modifying Therapy

ONTARGET
Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial
ORBIT-AF
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation
ORBITA
Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina
ORIGIN n-3 Fatty Acids
Investigators in the outcome Reduction with an Initial Glargine Intervention
OVIVA
Oral versus Intravenous Antibiotics for Bone and Joint Infection
Oscillate
Oscillation for Acute Respiratory Distress Syndrome Treated Early
PANTER
Minimally Invasive Step Up Approach versus Maximal Necrosectomy in Patients with Acute Necrotising Pancreatitis
PARADIGM-HF
Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure
PARTNER 2
Placement of Aortic Transcatheter Valves, Cohort A
PARTNER A
Placement of Aortic Transcatheter Valves, Cohort A
PARTNER B
Placement of Aortic Transcatheter Valves, Cohort B
PCPT
Prostate Cancer Prevention Trial
PEITHO
Pulmonary Embolism Thrombolysis trial
PESIT
Pulmonary Embolism in Syncope Italian Trial
PIONEER AF-PCI
Open-Label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects with AF who Undergo Percutaneous Coronary Intervention
PIONEER-HF
comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode
PIOPED II
Prospective Investigation of Pulmonary Embolism Diagnosis II
PLATO
Platelet Inhibition and Patient Outcomes
POET
Partial Oral Treatment of Endocarditis
POINT
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
POISE
PeriOperative ISchemic Evaluation
POISE-2 ASA
Perioperative ischemic evaluation 2 aspirin arm
POP-UP
Pantoprazole or Placebo for Stress Ulcer Prophylaxis
PRAMI
Preventative Angioplasty in Acute Myocardial Infarction
PRECISION
Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen
PREDIMED
Prevención con Dieta Mediterránea
PREPIC
Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group
PREPIC 2
Prevention du Risque d'Embolie Pulmonaire par Interruption Cave 2
PRODIGE 4 ACCORD 11
PRODIGE 4 Actions concertées dans les Cancers COloRectaux et Digestifs
PROFESS
Prevention Regimen for Effectively Avoiding Second Strokes
PRORATA
Procalcitonin to Reduce Antibiotic Treatments in Acutely ill patients
PROSEVA
Proning Severe ARDS Patients
PROTECT AF
WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation
PROVE IT-TIMI 22
Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22
PROWESS
Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis
PROWESS-SHOCK
Prospective Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis and Septic Shock
ProCESS
Protocolized Care for Early Septic Shock
RABBIT 2
Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes
RACE II
Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison between Lenient versus Strict Rate Control II
RAFT
Resynchronization–Defibrillation for Ambulatory Heart Failure
RALES
Randomized Aldactone Evaluation Study
RAVE
Rituximab in ANCA-Associated Vasculitis
RE-ALIGN
Randomized, Phase II Study to Evaluate the Safety and Pharmacokinetics of Oral Dabigatran Etexilate in Patients after Heart Valve Replacement
RE-COVER
Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism
RE-DUAL PCI
Randomized evaluation of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin in patients with nonvalvular atrial fibrillation undergoing percutaneous coronary intervention
RE-LY
Randomized Evaluation of Long-Term Anticoagulation Therapy
RED-HF
Reduction of Events by Darbepoetin Alfa in Heart Failure
REDUCE
Reduction in the Use of Corticosteroids in Exacerbated COPD
REDUCE-IT
Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial
RELAX
Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Heart Failure with Preserved Ejection Fraction
REMATCH
Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure
RENAAL
Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan
RESCUEicp
Randomised Evaluation of Surgery with Craniectomy for Uncontrollable Elevation of Intracranial Pressure
RESPECT
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment
ROCKET AF
Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation
ROSE
Reevaluation of Systemic Early Neuromuscular Blockade
SADHAT
Sertraline Antidepressant Heart Attack Randomized Trial
SAFE
Saline versus Albumin Fluid Evaluation
SALT-ED
Saline Against Lactated Ringer's or Plasma-Lyte in the Emergency Department
SAVE
Survival and Ventricular Enlargement Trial
SCD-HeFT
Sudden Cardiac Death in Heart Failure Trial
SEDCOM
Safety and Efficacy of Dexmedetomidine Compared with Midazolam
SELECT-D
Anticoagulation Therapy in Selected Cancer Patients at Risk of Recurrence of Venous Thromboembolism
SEPSISPAM
Sepsis and Mean Arterial Pressure
SHIFT
Systolic Heart failure treatment with the If inhibitor ivabradine Trial
SHOCK
SHould we emergently revascularize Occluded Coronaries for Cardiogenic shocK
SMART
Salmeterol Multicenter Asthma Research Trial
SMART
Isotonic Solutions and Major Adverse Renal Events Trial
SOAP II
Sepsis Occurrence in Acutely Ill Patients II
SOCRATES
Ticagrelor versus aspirin in stroke/TIA
SOLVD
Studies of Left Ventricular Dysfunction
SONIC
Study of Biologic and Immunomodulator Naive Patients in Crohn's Disease
SPACE
Strategies for Prescribing Analgesics Comparative Effectiveness
SPAF
Stroke Prevention in Atrial Fibrillation
SPARCL
Stroke Prevention by Aggressive Reduction in Cholesterol Levels
SPRINT
Systolic Blood Pressure Intervention Trial
SPS3-BP
Secondary Prevention of Small Subcortical Strokes-Blood Pressure
SPS3-Clopidogrel+ASA
Secondary Prevention of Small Subcortical Strokes clopidogrel+ASA
SPYRAL HTN-ON MED
Global Clinical Study of Renal Denervation With the Symplicity Spyral Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy
STAMPEDE
Surgical Treatment and Medications Potentially Eradicate Diabetes Efficiently
STAR
Study of Tamoxifen and Raloxifene (NSABP P-2)
STAR-D
Sequenced Treatment Alternatives to Relieve Depression
STICH
Surgical Treatment for Ischemic Heart Failure
STOPAH
Steroids or Pentoxifylline for Alcoholic Hepatitis
SUP-ICU
Stress Ulcer Prophylaxis in the Intensive Care Unit
SURTAVI
Safety and Efficacy Study of the Medtronic CoreValve System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement
SYNTAX
Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery
StiL
Study Group Indolent Lymphomas
TACTICS-TIMI 18
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban
TALC
Tiotropium Bromide as an Alternative to Increased Inhaled Glucocorticoid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid
TIMACS
The Timing of Intervention in Acute Coronary Syndromes
TIPPS
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia
TNT
Treating to New Targets
TONE
Trial of Nonpharmacologic Interventions in the Elderly
TOPCAT
Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist
TORCH
Towards a Revolution in COPD Health
TRAPS
Trial on Rivaroxaban in AntiPhospholipid Syndrome
TREAT
Trial to Reduce Cardiovascular Events With Aranesp Therapy
TRED-HF
Treatment for heart failure in patients with recovered dilated cardiomyopathy
TRICC
Transfusion Requirements in Critical Care
TRICS III
Transfusion Requirements in Cardiac Surgery
TRISS
Transfusion Requirements in Septic Shock
TRITON-TIMI 38
Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel–Thrombolysis in Myocardial Infarction 38
TRIUMPH
Transfusion Reduction Efficacy and Safety Clinical Investigation, a Randomized, Multicenter, Double-Blind, Placebo-Controlled, Using Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
TTM
Target Temperature Management 33°C vs. 36°C after Out-of Hospital Cardiac Arrest
UKPDS
United Kingdom Prospective Diabetes Study
UKPDS 34
UK Prospective Diabetes Study 34
UPLIFT
Understanding Potential Long-Term Impacts on Function with Tiotropium
V-HeFT
Vasodilator Heart Failure Trial
V-HeFT II
Vasodilator Heart Failure Trial II
VA NEPHRON-D
Veterans Affairs Nephropathy in Diabetes
VADT
Veterans Affairs Diabetes Trial
VALIANT
Valsartan in Acute Myocardial Infarction Trial
VANISH
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs
VASST
Vasopressin and Septic Shock Trial
Val-HeFT
Valsartan Heart Failure Trial
WARFASA
Warfarin and Aspirin
WASID
Warfarin-Aspirin Symptomatic Intracranial Disease
WHI E+P
Women's Health Initiative Estrogen and Progestin Trial
WISDOM
Withdrawal of Inhaled Steroids during Optimized Bronchodilator Management
WOEST
What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing
WOSCOPS
West of Scotland Coronary Prevention Study
iFR-SWEDEHEART
Instantaneous Wave-free Ratio versus Fractional Flow Reserve in Patients with Stable Angina Pectoris or Acute Coronary Syndrome
iPrEx
Iniciativa Profilaxis Pre Exposicion ("Preexposure Prophylaxis Initiative")